Background: The frequency of allergic diseases is increasing worldwide, particularly in industrialized countries. From a clinical, management, and public heath perspective, it is important to determine the reasons for consulting an allergist, the distribution by frequency of allergic diseases, and how health care is provided. Objective: Alergológica 2015 was carried out to obtain information on clinical practice in allergy departments in Spain, and compare it with the previous study editions. Methods: The data cover the year 2014 and the first quarter of 2015. The target sample was 6000 patients seen at public and private centers throughout Spain. A total of 500 allergists were invited to participate. Data were collected on an electronic case report form. Data were compared with the Alergológica surveys for 1992 and 2005 to identify differences. Results: The final study population comprised 2914 patients (mean age 33.6 [18.9] years, 58% women, 17% children), of whom 6.1% were foreign-born. The frequency distribution was as follows: rhinitis, 62%; asthma, 23.4%; drug allergy, 17.7%; urticaria/angioedema, 11.5%; food allergy, 10.4%; contact dermatitis, 4%; atopic dermatitis, 3%; insect venom allergy, 2%. A statistically significant increase was observed between data from 2005 and from 2015 with respect to the prevalence for allergic rhinitis, food allergy and drug hypersensitivity. An increase in the prevalence of a personal history of asthma, rhinitis, conjunctivitis, and eczema/atopic dermatitis were also observed. Besides, the number of relevant allergens in the same patient also increased. Most patients were referred from primary care, although a considerable percentage were referred by ENT specialists and dermatologists. Conclusions: Increasing trends were observed for allergic rhinitis, drug allergy, and food allergy, and a decreasing trend was observed for asthma. Findings for other diseases remained practically unchanged. Allergic patients are increasingly complex and present with a myriad of atopic manifestations.
Introduction
The frequency of allergic diseases is increasing worldwide, particularly in industrialized countries. From a clinical, management, and public heath perspective, it is important to determine the reasons for consulting an allergist, the distribution by frequency of allergic diseases, how the patient is referred to the specialist, and the diagnostic and therapeutic approaches used.
Allergy has been considered a full medical specialty in Spain since 1978, and the allergist is fully trained to treat all kinds of allergic diseases and allergic patients of all ages, from infancy to old age. Therefore, in 1992, the Board of Directors of the Spanish Society of Allergy and Clinical Immunology set up and carried out the first nationwide epidemiologic study, Alergológica 1992 [1] . Subsequent Boards of Directors published 2 new editions of this survey-Alergológica 2005 [2] and Alergológica 2015-with the same scope and based on the same methodology in order to be able to compare data.
The 2015 edition also included 2 complementary surveys: the National Allergy Map and the National Pharmacy Survey. The first was addressed to all allergists in charge of allergy departments/units or private offices and inquired about material and human resources, diagnostic procedures, and availability of special therapies (eg, desensitization to drugs and/or foods), as well as educational and investigational activities. The National Pharmacy Survey was designed by a committee of the Spanish Society of Community Pharmacy and aimed at community pharmacists with the aim of knowing the allergy-related health and educational needs of people using a pharmacy [3] . In this study, we present the main results of the epidemiological survey Alergológica 2015 for the adult population. Findings for patients aged <14 years will be presented in a separate publication.
Material and Methods
The main objective of the study was to obtain information on clinical practice in allergy departments in Spain. Data were collected from patients consulting an allergist for the first time in 2014 and the first quarter of 2015 in order to determine variations compared with data reported in the reports Alergológica 1992 and 2005.
We performed a cross-sectional, epidemiological, observational study by prospectively collecting information on patients seen for the first time at an allergology clinic. The target sample was 6000 patients seen at both public and private centers from throughout Spain. The inclusion criteria were as follows: the visit had to be the first with the investigator for the current complaint (the same patient could have been seen by the same investigator previously, although not for the current complaint); the visit had to be a scheduled appointment chosen randomly for each investigator; informed consent for clinical information to be used for purposes of scientific research.
We invited a total of 500 board-certified allergists to participate. The allergists were selected from the list of members of the Sociedad Española de Alergia e Inmunología Clínica (SEAIC [Spanish Society of Allergy and Clinical Immunology]). The distribution was similar to that of the Spanish population and of local subpopulations.
Data were collected on an electronic case report form (CRF) that included general demographic data and data on impact on quality of life and work, as well as specific questions for each major allergic disease presented by the patient. The CRF remained open until the diagnostic work-up had been completed for all patients or until the end of the recruitment period.
Qualitative variables were expressed as relative frequencies with their 95%CI. Quantitative variables were expressed as mean (SD); nonnormally distributed variables were expressed as median (IQR). Differences between qualitative variables were assessed using the chi-square or Fisher exact test. Quantitative variables were compared using the t test or Mann-Whitney test. An analysis of variance (or Kruskal-Wallis test) was performed for multiple comparisons, complemented with a Bonferroni or Tukey test where necessary. Statistical significance was set at P<.05.
The study was authorized by the Clinical Research Ethics Committee of Hospital General de la Defensa, Madrid, Spain.
The prevalence values of the different diagnoses varied widely between 2015 and 2005, with significant differences reported for rhinitis/conjunctivitis, bronchial asthma, food allergy, and drug hypersensitivity. In patients aged >14 years, significant differences were found for hypersensitivity to drugs (17.7% vs 14.7%; P=.0001) and to hymenoptera venom (2.0% vs 1.5%; P=.19) ( Table 1 ).
The vast majority of patients were seen in the public health sector (81.4%). More than half of the patients (60.2%) were referred from primary care (vs 52.6% in 2005). Only 15% were referred from other specialties (vs 43% in 1992), and most of these were from the ear, nose, and throat (ENT) clinic (22%).
Rhinoconjunctivitis
It is estimated that between 10% and 25% of the general public has rhinoconjunctivitis [4] , although figures vary depending on the population studied and its geographic distribution. The prevalence of allergic rhinitis in adults in Western Europe has been reported to be around 25% (21.5% in Spain) [5] .
Rhinoconjunctivitis was the main presenting complaint in Alergológica 2015, affecting 52.5% of patients, which was slightly lower than in 2005 (55.5%) and 1992 (57.4%). However, a final diagnosis of rhinoconjunctivitis was established in 62% of patients (rhinitis alone [36.9%], conjunctivitis alone [2.4%]), as compared with 54.7% in Alergológica 2005. The frequency of rhinoconjunctivitis was 3 times that of bronchial asthma (21%), the second most common presenting complaint in this edition of Alergológica (28% in 2005). It is noteworthy that 17.5% of patients consulted for both diseases simultaneously ( Figure 2 ).
The mean age was 29.9 (15.5) years. Most patients lived in an urban setting (65.1%), with the remainder in semiurban areas (24.3%), rural areas (10.3%), and industrial areas (0.35%). Patients lived with animals in 41.1% of cases (44.6% in 2005), and in most cases these were pets, with dogs clearly more common than other animals (29%). A family history of atopy-mainly rhinitis, asthma, and conjunctivitis-was and 24.8 [17.8] in 1992 [P<.0001]) ( Figure 1 ). Most patients were women (58% vs 42%), and most lived in urban areas (62%). As for socioeconomic characteristics, most patients had a medium-low level (48.8%) and medium-high level (40.5%). Slightly more than half of the study population reported a history of allergy among their immediate family (53%); this figure was similar to those reported in the previous surveys.
Patients aged ≤14 years accounted for 17% of the population. The mean age of this group was 7.6 (4.4) years (range, 4 months to 14 years), compared with 7.58 (3.9) in 2005.
It is noteworthy that the percentage of unemployed patients more than doubled between 2005 and 2015 (3.1% vs 7.9%). In 78.7% of cases, the patient was not occupationally exposed to allergens. In addition, the number of nonsmokers increased over the years (56% in 1992 to 70% in 2015). recorded in 62.7%. The percentage of smokers (12%) was lower than in previous years. We found that 70% of patients were referred to allergy clinics from primary care; this represents an increase over the previous 2 surveys. However, a notable decrease was observed in the number of patients referred from other specialists (from 43% in 1992 to 22.9% in 2005 and 10.9% in 2015; P<.0001 [chi-square]). This change is very relevant, with the ENT physician being the specialist who referred the largest number of patients with rhinoconjunctivitis. In 76.2% of cases, the patient visited the doctor because of an exacerbation (85.1% in 2005). The percentage of patients consulting for a first episode increased from 5% in 1992 to 14.9% in 2005 to 22% in 2015; these differences were very significant.
Patients had a 5-year history of rhinoconjunctivitis. At the time of the visit, the current episode had lasted 1.2 months. The etiology of rhinoconjunctivitis was allergic in 79.3% of patients (77.2% in 2005), with the most common allergens being the same as those in previous editions of the survey. However, in the present edition, pollen was the most relevant allergen (70.8% vs 51.9% in 2005), followed by mites, dander, and molds ( Table 2 ). Two-thirds of patients were sensitized to 1 group of allergens, 23.3% to 2 groups, and 10.1% to ≥3 groups (with "group" understood as a type of allergen, such as pollen, house dust mite, molds, and dander). Pollen was the only allergen involved in 42.2% of cases, house dust mite in 20.6%, dander in 1.2%, and molds in 0.9%. Among patients with ocular involvement, the origin was allergic in 92%.
According to the ARIA guidelines [4] , allergic rhinitis was persistent in 66% of patients presenting with a first episode. In terms of severity, 29.9% had mild rhinitis, 59.7% moderate rhinitis, and 8.7% severe rhinitis. These findings are consistent with those from previous studies in Spain [6] . In the present survey, it was proposed to classify allergic conjunctivitis according to its duration and severity [7] . Consequently, conjunctivitis was intermittent in 50.6% of The percentages do not total 100%, since several allergens may be relevant in the etiology of allergic rhinitis in a specific patient.
patients and persistent in 48.8%, mild in 50%, moderate in 47%, and severe in 1.6%. One novel aspect of the survey in comparison with the previous editions is the evaluation of quality of life in patients aged >14 years using the ESPRINT questionnaire [8] , which examines 4 dimensions: symptoms, activities of daily living, sleep, and psychological aspects. The dimension most affected in patients with rhinitis was symptoms (mean score, 2.14), followed by sleep (mean score, 1.75).
The most widely used resources for diagnosis of rhinoconjunctivitis were the clinical history and physical examination (99.1%). Skin prick tests were used in 97.5% of patients, and the most requested test was determination of IgE (total and specific) in 46.3%.
As for therapy, antihistamines (mainly oral) were the most widely prescribed drug (92.6%), followed by nasal corticosteroids (70.6%). Avoidance of the allergen was recommended in 72.5% of patients, and specific immunotherapy was indicated in 31.3% (subcutaneous in 85.8%).
Bronchial Asthma
A total of 618 patients (21.2%) had bronchial asthma. This prevalence is considerably lower than in 1992 (35%) and 2005 (28%). According to data from the European Community Health Survey [9] , the prevalence of asthma in Spain was low, although notable regional variability was observed (Albacete, 10%; Barcelona, 5%; Galdácano, 14.5%; and Oviedo, 9.4%) [10] .
The mean age of patients with asthma was 29.5 (17.2) years, with peaks for children aged 5-15 years and adults aged 35-40 years. Women accounted for 55% of cases. The area of residence was urban and semiurban for most patients (59.1% and 20.8%, respectively), in apartment buildings (58.8%) and houses (41.2%). Patients reported contact with animals (at home or otherwise) in 42.3% of cases (46.6% in 2005 and 41% in 1992), with dogs being the most common pet (45.2%).
Patients were generally referred from primary care (74% vs 50.9% in 2005), mainly family doctors. The specialists who referred the patients to the allergologist were respiratory specialists (38.8% vs 21.3% in 2005), ENT specialists (19.4% vs 11.8% in 2005), and dermatologists (10.5%). Most patients with asthma were nonsmokers, with only 17.2% being active smokers (14.4% in 2005) . Patients reported a family history (first-degree relative) of asthma in 39.3% of cases and rhinitis in 46.8%. As for personal history, 20% of patients reported having being previously diagnosed with asthma and 16.5% with rhinitis. The main presenting complaints were dyspnea in 72.5%, nasal symptoms in 73.4%, cough in 64.3%, breath sounds in 31.5%, and ocular discomfort in 49.2%.
Quality of life was generally good among patients with asthma, and findings were better for mobility and self-care among this group than in the general population.
Asthma was intermittent in 38.3% of cases and persistent in 57.5% (4.3% did not respond). Figure 3 shows the classification of the patients by severity according to the Spanish Guidelines for Asthma Management (GEMA) [11] .
Disease was controlled in 35% of patients. Control was classified according to the GEMA guidelines [11] as good in 35%, partial in 31%, and poor in 10% (28% did not complete this section).
Asthma was extrinsic in 82.2% of patients and intrinsic in 16.8%. Women accounted for 62.5% of cases of intrinsic asthma. Most patients with extrinsic asthma were sensitized to pollen, followed by house dust mite, and, at some distance, animal dander and other aeroallergens. The prevalence of sensitization to pollen increased by 50% between 2005 and 2015 (vs by 10% between 2005 and 1992) ( Table 3) . Analysis of the frequency of sensitization by region revealed 2 clear patterns: sensitization was mainly to house dust mites in coastal regions and the islands and to pollens in the interior. The geographic and climatic peculiarities of some areas (eg, Andalucía and Navarra) took the form of a mixed pattern, with high percentages of sensitization to both pollen and mites. Sensitization to animal dander (dog and cat) was highest in Madrid, La Rioja, and the Canary Islands, and sensitization to molds was highest in Murcia, Valencia, Extremadura, and Castilla-La Mancha.
The prevalence of occupational asthma was very low (1% vs 1.2% in 2005).
Asthma was associated with respiratory infection in 32.4% of patients and with rhinitis in 80.6%.
The main parameters used to diagnose asthma were clinical history and physical examination (99.4%), blood biochemistry and complete blood count (38.9%), spirometry (87.3%), bronchodilator response (62.6%), skin test results (type 1, 77.1%), fraction of exhaled nitric oxide (FeNO, 21.8%), bronchial challenge (6.7%), total IgE (46.5%), and specific IgE (48.6%). Of note, the frequency of use of FeNO was significantly greater than in 2005 (1.9%).
As for treatment, 91.3% of patients reported that they had received treatment during the previous year. Once the asthma work-up had been performed and the diagnosis confirmed, the main treatments prescribed were allergen avoidance (73.3%), inhaled bronchodilators (78.6%), topical corticosteroids alone (24.4%), corticosteroids combined with long-acting ß-agonists (51.8%), specific immunotherapy (27.7%), antihistamines (41.6%), and antileukotrienes (21.7%). Omalizumab was prescribed to only 0.7% of those finally diagnosed with asthma. In 57.1% of cases, the allergologist made at least 2 changes in the treatment prescribed by the nonspecialist. The main changes included an increase in the use of inhalers with the combination of inhaled corticosteroids and longacting ß-agonists (which increased by 33% [38.5% in 2005]), increased prescription of antihistamines (41.6% vs 29.8% in 2005), and the introduction of omalizumab, which was not recorded in 2005. All other therapeutic options remained practically unchanged compared with the previous survey. 
Drug Hypersensitivity
Drug allergy was the third most frequent reason for visiting the allergologist. In 2015, a total of 544 patients consulted for possible drug allergy, that is, 18.7% of the study population (14.7% in 2005) . This percentage is indicative of the constant increase in this type of allergy since 1992 (12.6%).
Mean age was 42.3 (20.1) years (41.4 [19.4] in 2005), which was higher than that reported for the general population (31.5 [18] years), probably owing to the lower number of children (9% vs 9.8% in 2005) among those who consulted for drug allergy (19.4% vs 18.37% in 2005) . The percentage of children who consulted for drug allergy in 1992 was 12.5%. Drug allergy was more prevalent in women (2:1 ratio). The percentage of patients with a family history of atopy was greater than in previous editions of the survey. The same was true for personal history (18% vs 2% in 2005).
It seems that an increasing number of patients are being referred from primary care (65.2% vs 61.0% in 2005 and 55.0% in 1992). Patients were referred by other specialties, with most from the emergency department (14.9%), internal medicine (10.5%), dermatology (8.8%), anesthesiology (6.2%), respiratory medicine (4.4%), and ENT (1.8%). The mean time on the waiting list was 54.8 (66.6) days, although this tended to decrease (82 [114] in 2005 and 107 [158] in 1992). The visit was for a first episode of drug allergy in 79% of cases, which is clearly higher than that reported for other first visits (P<.0001, Fisher exact). The median time between the first reaction and the visit was 6.5 (0-600) months (20 in 2005). The median time between the last reaction and the visit was 40 (20-100) days (90 in 2005). The main reason for consultation was a probable drug reaction (78.3%), followed by skin reactions (17.8%).
Patients who consulted for drug reactions had a higher prevalence of comorbidities in all cases. In 27% of cases, the patient had another allergic disease. Diagnosis of drug allergy was confirmed in 16% (26.6% in 2005) and ruled out in 29% (37.2% in 2005). The diagnosis was suspected in 55% (36.2% in 2005). The underlying hypersensitivity mechanism was immediate in 55.2%, deferred in 3.8%, delayed in 30%, and other in 11%. In children, the reaction was immediate in almost of half of the cases. Symptoms were mainly cutaneous (81.6% vs 75% in 2005), although anaphylaxis (8.1%), asthma (3.9%), and others were also reported ( Table 4 ).
In 2015, 45.7% of reactions were to 1 drug (82% in 2005), 44.2% were to 2 drugs (14% in 2005), and 10.2% were to 3 or more drugs (4% in 2005). As in the previous editions of the survey, ß-lactams and nonsteroidal anti-inflammatory drugs were the most frequently involved classes. Amoxicillin was the culprit drug in almost one-third of reactions. Comparative data are shown in Table 5 
Urticaria and Angioedema
Of all the patients seen at allergy clinics during 2015, a total of 336 (11.5%) were diagnosed with urticaria ± angioedema. This finding was similar to that reported in 2005 (11%). Although prevalence was slightly higher in the overall sample than in patients aged <14 years (12.4%), the results are not statistically significant.
The mean age of patients with urticaria/angioedema was 36.8 (19.6) years, which was similar to that recorded in 2005 (35.75 [18.9] years). The number of females affected (64%) was significantly higher than the number of males, and 28.1% of patients had pets at home (59.7% in 2005).
As for family history, no differences were recorded between the overall sample and patients with urticaria/angioedema. The personal history of patients with urticaria/angioedema was similar to that of the overall population, with rhinitis and The impact on patient quality of life was evaluated using the EQ-5D-5L questionnaire [12] , which revealed that, compared with the general population, patients with urticaria/angioedema were more affected in dimensions such as activities of daily living, pain/malaise, and anxiety/depression.
Urticaria was classified according to its duration, frequency, and cause. The most common type was acute urticaria (57.7% of all patients who consulted for this reason), with a duration of <6 weeks; the remainder (42.3%) consulted for chronic urticaria. In the case of patients with chronic urticaria, 56.9% had recurrent flare-ups. No significant differences were detected with respect to the data obtained in 2005. Urticaria was the only presentation in 58.9% of patients (56.8% in 2005), and angioedema was the only presentation in 14 In the vast majority of cases, urticaria was diagnosed using the clinical history and physical examination (90%), as well as skin testing with food allergens (69%) and aeroallergens (59%). Various types of blood testing were used in approximately half of the patients. These findings differed from those reported for diagnosis of urticaria in 2005. However, in the case of patients with chronic urticaria, the work-up was performed based on an immunological study (almost 70% [67.7% in 2005]) and skin tests with food allergens (70.4% [70.2%]) and aeroallergens (62% [62.5%]). These findings were similar to those reported in 2005.
Chronic urticaria was classed as idiopathic in 60% of cases. When the cause was known, this was identified as physical (including cholinergic urticaria) in 68.4% of patients. Alergológica 2015 reports a relevant finding that was not examined in 2005, namely, the percentage of patients who reported exacerbation with NSAIDs (20.83% in acute urticaria and 19.3% in chronic urticaria). This finding is similar to those reported in the few available studies [13] .
As for treatment, 83.3% of patients received antihistamines (73.3% in 2005). Of these, 72.6% were second-generation or nonsedating. Of note, almost 10% of patients (17% in 2005) made some adjustment to their diet, and almost 20% (9.1% in 2005) were prescribed corticosteroids. 
Food Allergy
In 2015, the prevalence of food allergy in Spain among patients who visited the allergologist for the first time was 11.4% (7.4% in 2005 [14, 15] ). As in 2005, food allergy was the fifth most common disease. The allergology study, which followed the same methodology as in 1992 and 2005, is a very useful approach for establishing trends in the frequency of the disease. A comparison of trends shows that the frequency of food allergy has increased by almost 3-fold in Spain in slightly over the last 2 decades from 3.6% in 1992 to 7.4% in 2005 to 11.4% in 2015. The age distribution has changed as compared with Alergológica 2005 (Figure 4) , with a decrease in infants and small children and an increase in young adults.
If we consider the suspected diagnosis (history and examination) with respect to the previous edition, we see that food allergy now includes an emerging disease, namely, eosinophilic esophagitis, which was the suspected diagnosis in 0.62% of patients who consult for the first time. Despite being an uncommon disease, eosinophilic esophagitis is frequently diagnosed in allergy clinics.
Patients with food allergy were aged between 0 and 69 years (mean, 25.4 [17.8] years), and more than half were women (56.4%). A family history of atopy was reported in 64.7% of patients (in remission in 39.3% and active in 46.8%). The personal history included allergy to other foods (15.1%), followed by rhinitis (23.9%) and atopic dermatitis (11.5%).
More than half of the patients (54%) were referred to the allergologist by a primary care physician (50.4% in 2005); 30.8% were referred by other specialists (pediatrician in 15% [23.7% in 2005]). Patients visited the allergologist of their own accord in 13.7% of cases (13.8% in 2005). Two-thirds of patients (65.4%) went to their primary care physician because of allergy during the previous 3 months, and 42.2% (52.1% in 2005) had visited the emergency department because of allergy, with a mean frequency of 1.4 (0.8) visits. The patient had consulted another specialist in 21.6% of cases.
Parents had to miss a mean of 3.1 (2.1) days of work because of their children's food allergy in 18.5% of cases (17.6% in 2005). Students missed a mean of 4.9 (4.7) days (median, 3 days) because of their allergy.
The main reason for consultation among food-allergic patients in 2015 was reactions to foods (52.9%). The consultation was for a first reaction (flare) in 46.5% of cases (60.7% in 2005), whereas in 53.5% of cases (39.3% in 2005), the patient had had previous reactions.
The main causes of food allergy were fruits (44.7%), tree nuts (28.4%), and shellfish (14.8%). Within the category of fruits, Rosaceae induced reactions in 59.4% of patients. Within the category of shellfish, 93.6% of reactions were caused by crustaceans. When the foods involved in the different age groups were compared between the 3 surveys (1992, 2005, and 2015), the percentages remained unchanged, as did the order of frequency ( Figure 5 ).
The most common type of manifestation in food-allergic patients was cutaneous (56.8%), followed by oral allergy syndrome (36.6%), and digestive symptoms (18.7%). Anaphylaxis was recorded in 12.1% of patients (17.9% in 2005), asthma in 3.6%, rhinitis in 3.3%, and exercise-induced anaphylaxis related to food allergy in 1%. In 2015, fish was the food that most frequently produced anaphylaxis.
A clinical history was taken and a physical examination performed in almost all patients with food allergy. Skin prick tests were performed in 94.8% (95.9% in 2005), with no significant variations in their frequency of use according to the food. Specific IgE was determined in 67.8%. An avoidance diet was used for diagnostic purposes in 29.1%, and oral challenge tests were applied in only 15.6% (13% in 2005). The diagnosis was based on the clinical history and presence of specific IgE to the food demonstrated in skin tests (mainly), serum, or both in at least 60.2% of cases.
The most frequent therapeutic approach was food avoidance (97.3% vs 93% in 2005). Antihistamines were recommended in 80.7% (35.2% in 2005) and corticosteroids in A total of 124 cases of contact dermatitis were diagnosed, that is, 4.3% of the total sample. This percentage was similar to that reported in 2005 (4.2%) and higher than that reported in 1992 (2.4%). Mean age was 44.4 years (42.6 in 2005). Contact dermatitis was twice as prevalent in women as in men.
The patient was in contact with allergens at work in 13.4% of cases and not in contact in 41.2%. Homemakers and unemployed persons (12.4% and 7.7%, respectively) accounted for a lower percentage of the total sample than patients with contact dermatitis (22.3% and 11.6%, respectively). A personal history of eczema was recorded for 15.3% of patients, which is higher than in the other patients in the sample, of whom only 7.2% had a personal history of eczema.
The reason for consultation was a skin problem in 83.3% of patients. More than half were referred from primary care (56.5%), 23.4% were referred from other specialists, and 11.3% consulted of their own accord. The main referring specialty was dermatology (75.9%). Most patients diagnosed with contact dermatitis (88%) had presented with classic dermatitis caused by contact with a substance. The origin was considered allergic in 54% of cases and irritant in 31.3%. Photoallergy and phototoxicity were less common (3%), as was dermatitis caused by an airborne agent (4%) or medication (9%). The origin was occupational in only 11% of cases. Most cases of dermatitis were classified as chronic (51%), although up to 38% were classified as acute.
Diagnosis was mainly by taking a clinical history and performing a physical examination (92.44%). In the case of contact dermatitis, it was mainly by specific tests (83%), including patch tests in 76.5%, photopatch in 2.5%, and late-reading intradermal tests in 4.2% of cases. Patch tests were performed using a standard series in 91% of cases, with additional contact allergens used in 40%. Patch testing was positive in 52.7% of patients assessed (69.3% in 2005). The main causes of allergic contact dermatitis were nickel sulfate (50.0%), potassium dichromate (18.8%), methylchloroisothiazolinone + methylisothiazolinone (Kathon CG) (11.4%), cobalt chloride (9.1%), paraphenylenediamine (6.8%), formaldehyde (4.5%), quaternium-15 (4.5%), and fragrances (fragrance mix I and fragrance mix II) (2.3%). However, 20% of cases were caused by substances not included in commercially available series.
The most frequent recommendation for therapy was avoidance of the allergen in 75% of cases, followed by topical corticosteroids in 48%. Calcineurin inhibitors were recommended in only 7% of patients. No treatment was prescribed in almost 8% of cases.
Atopic Dermatitis
In the present survey, a total of 98 patients (56.5% females and 43.5% males; 60% children, 40% adults) visited the allergologist because of atopic dermatitis, that is, only 3.4% of the whole study population, as was the case in 2005 (3.4%). Patients aged 0 to 5 years accounted for 28.6% of those affected, patients aged 6-15 years for 31.9%, and patients aged >15 years for 39.6%. The prevalence was 7.5% among foreign-born patients and 3.1% among Spanish patients. Onset was before 2 years of age in 47% of the sample and before 7 years of age in 74%; however, the mean age at the first visit to the allergologist was 17.8 years.
Almost three-quarters of patients with atopic dermatitis (74.5%) had a family history of atopy, and 58.2% had a personal history of atopy. The disease involved was atopic dermatitis in 40.8%, rhinitis in 17.4%, conjunctivitis in 12.2%, and bronchial asthma in 11.2%. Only 7.1% of patients reported a personal history of food allergy in remission, and 6.1% reported an active history of food allergy.
Most patients were referred by their family physician (32.6%) or pediatrician (34.8%) and consulted mainly for cutaneous symptoms (54%), although in 87% of cases these were associated with other symptoms, mainly respiratory symptoms.
The main diagnostic tests used were the prick test (72.9%), followed by determination of serum total IgE (30%) and specific IgE (29%). Patch testing with aeroallergens and foods was a novelty in 2005 compared with 1992. In the present survey they were used in a small percentage of patients (2.1% and 2.1%, respectively). Oral challenge testing was used in 5.2% of patients with atopic dermatitis.
Atopic dermatitis was classified as idiopathic in 62% of cases (ie, equivalent to the nonatopic form of dermatitis), and in 38% of cases it was associated with allergens (ie, the atopic form). These percentages were similar to those recorded in 2005 (idiopathic, 58%; allergens, 42%) and 1992 (idiopathic, 57%; and allergens, 43%). Atopic dermatitis was considered to be idiopathic in 91% of patients who presented with dermatitis only.
Treatment of atopic dermatitis was mainly with moisturizing agents (93.8%), followed by antihistamines (62.5%) and topical corticosteroids (61.4%). Topical calcineurin inhibitors were prescribed in 11.5% of patients (31.0% in 2005) and systemic corticosteroids in 5.1% (4.1% 2015).
Allergy to Hymenoptera Venom
A total of 73 patients (2.5%) were allergic to insect stings (77 [1.5%] in 2005). Most patients were men aged 20 to 50 years. The area of residence was rural in 23.9% (33.3% in 2005), and 45.7% lived in a house (45.3% in 2005), as opposed to an apartment. A personal history of asthma was recorded in 6.9% of patients, rhinitis in 16.4%, and atopic dermatitis in 1.4%. These values are lower than those recorded for other allergic diseases.
Patients were referred from another specialty in 11.4% of cases; in 62.5%, the specialty was emergency medicine (36.8% of cases in 2005 were from the emergency department Epinephrine was the treatment administered after the sting in 16 of the 70 cases (22.9%) for which data were available. Thirteen (18.6%) were managed in the emergency department during the previous year, and 2 (12.5%) were admitted. Furthermore, 93.8% received antihistamines, and 15 (93.8%) received corticosteroids. Epinephrine was recommended in 42.9% of cases (55.8% in 2005), and immunotherapy was recommended in 35.7% (49.4% in 2005).
Other Allergic and Nonallergic Diseases
Other allergic diseases were diagnosed in 104 patients, that is, 3.6% of the population (45 patients [0.9%] in 2005). Age ranged between a few months and 90 years, with a mean age of 40.4 (18.7) years. Males accounted for 49.5% of the group and women 50.5%.
Patients consulted of their own accord (13.1% vs 11.4% in 2005) or were referred by their family physician (50.5% vs 63.6% in 2005) or another specialist (31.3% vs 25% in 2005). Of note, no cases were referred from internal medicine in 2015. The number of cases from pediatrics decreased considerably from 27.3% to 4%. Also of interest is the notable increase in referrals by digestive specialists (18.2% to 41.9%), possibly as a reflection of the recent considerable increase in the frequency of eosinophilic esophagitis and other digestive diseases with a possible allergic origin, thus leading to referral for an etiological study.
The 3 most frequent final diagnoses were nonspecified cough (31.7%), contact dermatitis (20.2%), and allergic . Patients attended of their own accord in 9.2% of cases or were referred by their family physician in 53.2% of cases. Referral was by another specialist in 28.4% of cases (ENT, 23.3%; respiratory medicine, 20%; and dermatology, 13.3%); 9.2% were referred by a primary care physician.
The definitive diagnosis of other nonallergic diseases is shown in Table 8 . The percentage of "other diseases", that is, those that cannot be defined clearly, is noteworthy (74.3%).
Discussion
The main objective of Alergológica 2015 was to obtain data from daily clinical practice on patients consulting an allergologist for the first time during the year 2014 and first quarter of 2015. The data were compared to identify differences with the surveys carried out in 1992 and 2005. Although the sample size was notably lower than that of previous studies (4005 patients in Alergológica 1992 and 4991 in Alergológica 2005 vs 2914 in Alergológica 2015), the statistical power was sufficient to allow for comparisons. The reasons for this lower recruitment rate may be the use of an electronic CRF for the first time in the latest edition, with technical access difficulties from many public centers, and the lack of budget for the investigators' remuneration.
The areas examined to investigate differences were the same as in previous editions and focused on epidemiology, seasonality, diagnosis (clinician involved and techniques used), and therapy for the different allergic diseases. Alergológica 2015 was based on data from almost 200 allergy clinics, two-thirds of which belong to the Spanish National Health System, the remainder being private centers. The geographical distribution of the patients included was representative of the Spanish population. Therefore, although the Alergológica studies are not population-based epidemiological studies that would yield prevalence data in the general population, they show the trends in allergic diseases over the last 20 years in Spain.
The most significant changes observed were for the prevalence of rhinoconjunctivitis, which increased, and the prevalence of bronchial asthma, which decreased. Significant increases in prevalence were also observed for food allergy, drug hypersensitivity, and other allergic diseases. The prevalence of other nonallergic diseases decreased significantly ( Table 1) .
As in previous editions, most patients were referred from primary care (60.2%), potentially reflecting the higher number of joint activities between Spanish allergists and primary care physicians in the last decade. Notwithstanding, a considerable percentage (15%) were referred by ENT specialists and dermatologists, which are the specialties most closely related to allergy. The fact that referrals from pediatricians have decreased may be due to the inclusion of fewer pediatric patients in the present edition.
In the case of rhinoconjunctivitis in particular, one of the most notable observations was that of a more diverse range of allergic manifestations in the same person. A statistically significant increase was observed between data from 2005 and from 2015 with respect to personal history of asthma, rhinitis, conjunctivitis, and eczema/atopic dermatitis. Besides, the number of relevant allergens in the etiology of allergic rhinitis in the same patient has also increased. This reflects the reality of observations from daily clinical practice, which show that allergic patients are more complex and present with a myriad of atopic manifestations. This observation also highlights the importance of treatment by a fully trained allergy specialist.
Data from the European Community Health Survey [9] show that the prevalence of asthma in Spain is low, albeit with notable regional variability [10] . Bronchial asthma was recorded in slightly more than 20% of the study population, which is considerably lower than in the previous surveys. The reasons for this are uncertain, although one explanation may be that education on asthma management among primary care physicians has improved considerably in recent years and many asthmatic patients are being treated in primary care. A key finding was the dramatic increase in the use of FeNO (1.9% in 2005 vs 21.8% in 2015), although according to clinical practice guidelines [16] , the technique is still considered inappropriate for phenotyping asthma. The use of other diagnostic tests remained largely unchanged, with the more notable differences being recorded for spirometry and the bronchodilator test (slightly increased).
Drug allergy was the third most frequent reason for visiting the allergologist, significantly more than for other first visits, and the frequency has increased gradually since 1992 (12.6% vs 14.7% vs 18.7%). In addition, more patients had a personal and family history of drug allergy than in previous surveys. ß-Lactams and nonsteroidal anti-inflammatory drugs continued to be the most involved drug classes.
Urticaria/angioedema is one of the most common complaints both in primary and in specialized care. Yet, there is a notable lack of published epidemiological data on this disease [17] . The prevalence of urticaria was similar to that detected in 2005, and the disease remains the fourth most common reason for visiting the allergologist after rhinitis, asthma, and drug allergy. Likewise, the care provided reflected that of Alergológica 2005, with an increased number of outpatient visits. Treatment of urticaria was similar to that reported in 2005, with the exception of prescription of corticosteroids, which more than doubled since 2005. Of note, treatment of chronic spontaneous urticaria with omalizumab was approved in Spain in January 2014 [18] . At that time, practice guidelines recommended the use of omalizumab as an alternative therapy when other immunosuppressants were not appropriate [19] . Therefore, it is very unlikely that this drug is prescribed to a patient attending an allergy unit for the first time, and this may explain why it was not recorded as a therapeutic option in Alergológica 2015.
Recent population-based studies [20] [21] [22] [23] calculate the prevalence of food allergy to be 1%-3% of the population, although it can reach 8% in children aged <3 years. A comparative analysis of the 3 Alergológica studies revealed that the frequency of the foods involved remains unchanged. However, a gradual increase in the frequency of allergy to fruits and tree nuts and a decrease in allergy to milk and egg can be observed, while that of allergy to fish is maintained. The differences can be explained by the low percentage of pediatric patients (17%). The median age in Alergológica 2015 was 33 years, and only 3% of patients were aged <5 years, which is the age group with the highest frequency of allergy to milk and egg.
Oral immunotherapy is becoming increasingly popular in more specialized allergy departments [24] , although in the present study, it was administered in only 3% of cases. This treatment modality is not initially offered to a recently diagnosed patient. It is generally offered when the patient's progress has been followed over time and persistence of allergy is confirmed. In addition, since it is usually only administered to the age group most affected by allergy to egg or milk, ie, patients aged <5 years, the percentage of cases reported in the present study was very low (3%).
The most interesting finding with respect to other allergic and nonallergic diseases in Alergológica 2015 was the absence of referral from the internal medicine department and the considerable decrease in the number of referrals from pediatricians (27.3% to 4%). Also noteworthy is the increase in referrals from the digestive medicine department (18.2% to 41.9%), probably due to the prevalence detected in recent years of eosinophilic esophagitis and other gastrointestinal disorders with a possible allergic origin that require an etiological workup by an allergologist.
In the case of contact dermatitis, prevalence can be considered lower than expected, given that the prevalence of allergic contact dermatitis (sensitization to a specific contact allergen) in the general population is around 20% [25] or even 27% in the most recent European studies [26] . Also noteworthy is the low prevalence of contact dermatitis in persons aged <18 years, especially given that the prevalence of this disease has increased during the last decade [27] . Only 11% of cases were occupational. This low percentage is striking, since contact dermatitis is one of the most common occupational diseases. The explanation for this may be that patients with suspected occupational contact dermatitis may be referred from their primary care physician or from the medical surveillance service at their jobs to the dermatologist in the first place or to units specialized in this disease.
The prevalence of atopic dermatitis remained unchanged (3.4% in 2015 and 2005) and was slightly higher than in 1992 (2.5%). While this may seem low, stratification by age group reveals higher figures in children. Similarly, few changes were recorded with respect to type of referral (two-thirds from primary care physicians and pediatricians). Consistent with findings from other studies, more women had atopic dermatitis than men [28, 29] . While sex does not seem to be an independent risk factor for atopic dermatitis [30] , some authors report that women find it easier to describe their symptoms [31] . In addition, given that diagnosis is based on well-established clinical findings [31, 32] , it is striking that the disease was suspected in only 56.3% of patients. This could be explained by the fact that patients may not have had skin lesions at their first visit. In any case, the median time to diagnosis was 1 day, although diagnosis took more than 5 days in slightly more than 20% of cases, probably because of the presence of other allergic diseases requiring additional testing.
Allergy to hymenoptera venom was more prevalent among males (56% vs 42%), because men are more likely to work in the open air and be beekeepers, and among people living in the countryside. Most patients were referred from the emergency department and had been treated with antihistamines, corticosteroids, and epinephrine. Consequently, the waiting list is shorter than in the general sample (43.5 vs 57.8 days), mainly because the reaction is acute and severe and must be managed as soon as possible with immunotherapy. In addition, allergologists are particularly sensitive to this condition.
In summary, Alergológica 2015 is the third edition of the Alergológica series, which was started by the Spanish Society of Allergy and Clinical Immunology in 1992. The study evaluates several areas of daily clinical practice in the treatment of allergic diseases presented by patients seen for the first time in allergy clinics. The study included 2914 patients from more than 200 allergy units in both the public and private health care systems in Spain. The results of the current edition show a similar distribution in the frequencies of allergic rhinitis, asthma, and drug allergy, which are the 3 main diseases diagnosed. Increasing trends were observed for allergic rhinitis, drug allergy, and food allergy, and a decreasing trend was observed for asthma. Findings for other diseases remained practically unchanged.
